Kateshali Arash Farahmand, Moghzi Faezeh, Soleimannejad Janet, Janczak Jan
School of Chemistry, College of Science, University of Tehran, P.O. Box 14155-6455, Tehran, Iran.
Institute of Low Temperature and Structure Research, Polish Academy of Science, 50-422, Wrocław, Poland.
Sci Rep. 2025 May 9;15(1):16216. doi: 10.1038/s41598-025-94147-2.
During the initial week after birth, a majority of newborns experience hyperbilirubinemia and jaundice as a result of the build-up of unconjugated Bilirubin (BR) in their bloodstream. If elevated BR levels are not adequately addressed, it could result in brain damage. Despite advancements in luminescence-based sensing technology for clinical purposes, there remains a significant demand for diagnostic devices with accurate, specific, portable, and affordable features. We present a luminescent nanopaper-based assay kit for visual recognition of BR. This novel kit comes with a smartphone readout, enabling effortless recognition of BR. To develop the kit, a new d - f heterometallic MOF {[CeZn(pzdc)(HO)]·2HO} (pzdc = 2,3-pyrazinedicarboxylic acid) (CeZn-MOF) with advantageous photophysical features was grown on bacterial cellulose (BC) nanofibers to form BC@CeZn-MOF platform. The platform's luminescence quenches in the presence of BR with a turn-off mechanism originating from Inner Filter Energy (IFE). The luminescence quenching was linearly proportional to the concentration of BR in range of 0.1 - 20 mg.dL (LOD = 0.027 mg.dL), and recognition of small amount of BR could be attained with a smartphone camera. Furthermore, the luminescence emission of the sensing platform was recovered upon UV light (470 nm) through photo-isomerizing of BR into lumirubin as a non-PL quencher. The kit's feasibility was confirmed through validating its practicality for detecting BR in human serum samples and its compatibility with clinical procedures. The non-poisonous nature and distinctive photophysical characteristics of platform makes it an excellent choice, easy-to-use BR recognition assay kit.
在出生后的第一周,大多数新生儿会因血液中未结合胆红素(BR)的积累而出现高胆红素血症和黄疸。如果BR水平升高得不到充分处理,可能会导致脑损伤。尽管基于发光的传感技术在临床应用方面取得了进展,但对具有准确、特异、便携且价格合理特点的诊断设备仍有巨大需求。我们展示了一种用于视觉识别BR的基于发光纳米纸的检测试剂盒。这种新型试剂盒配有智能手机读数功能,能够轻松识别BR。为开发该试剂盒,一种具有有利光物理特性的新型d - f异金属MOF {[CeZn(pzdc)(H₂O)]·2H₂O}(pzdc = 2,3 - 吡嗪二甲酸)(CeZn - MOF)生长在细菌纤维素(BC)纳米纤维上,形成BC@CeZn - MOF平台。在BR存在时,该平台的发光会淬灭,其关闭机制源于内滤光能量(IFE)。发光淬灭与BR浓度在0.1 - 20 mg·dL范围内呈线性比例关系(检测限 = 0.027 mg·dL),并且使用智能手机摄像头就能识别少量的BR。此外,通过将BR光异构化为作为非光致发光淬灭剂的光红素,传感平台的发光在紫外光(470 nm)照射下得以恢复。通过验证该试剂盒在检测人血清样本中BR的实用性及其与临床程序的兼容性,证实了其可行性。该平台无毒的性质和独特的光物理特性使其成为一种出色的、易于使用的BR识别检测试剂盒。